Lack of natural killer cell augmentation in vitro by human interferon gamma in a subset of patients with systemic sclerosis

Ajay Wanchu, V. K. Singh, V. S. Yadav, S. Biswas, R. Misra, S. S. Agarwal

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Systemic sclerosis (SSc) is a generalized connective tissue disorder characterized by fibrosis of skin and various viscera. Natural killer (NK) cells are a subset of lymphocytes that can lyse targets without prior sensitization. Few studies have tried to assess NK cell function in patients with SSc. To evaluate NK cell cytotoxicity in patients with SSc and to see the extent of its augmentation in vitro by human interferon (hIFN) gamma in the clinical subset of limited and diffuse cutaneous diseases, we evaluated 27 patients with SSc and 22 age- and sex-matched controls by 51Cr release assay. Fifteen patients had limited cutaneous disease (mean disease duration 6.2 ± 2.7 years) and 12 diffuse cutaneous disease (mean disease duration 5.7 ± 2.4 years). Patients with limited SSc had significantly higher baseline NK cell function than controls (p <0.05) and the augmentation following in vitro stimulation with hIFN gamma was negligible. Patients with diffuse SSc had lower baseline NK cell cytotoxicity than controls but this was not statistically significant. Augmentation with hIFN gamma in this group was comparable to controls. This study suggests that NK cells may have a role in the pathophysiology of this disease.

Original languageEnglish (US)
Pages (from-to)288-292
Number of pages5
JournalPathobiology
Volume63
Issue number5
StatePublished - 1995
Externally publishedYes

Fingerprint

Systemic Scleroderma
Natural Killer Cells
Skin Diseases
Cytotoxicity
Diffuse Scleroderma
Viscera
Lymphocytes
Lymphocyte Subsets
Connective Tissue
human IFNG protein
In Vitro Techniques
Assays
Skin
Fibrosis
Tissue

Keywords

  • Interferon
  • Natural killer cells
  • Systemic sclerosis

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Clinical Biochemistry
  • Immunology and Allergy
  • Cell Biology

Cite this

Wanchu, A., Singh, V. K., Yadav, V. S., Biswas, S., Misra, R., & Agarwal, S. S. (1995). Lack of natural killer cell augmentation in vitro by human interferon gamma in a subset of patients with systemic sclerosis. Pathobiology, 63(5), 288-292.

Lack of natural killer cell augmentation in vitro by human interferon gamma in a subset of patients with systemic sclerosis. / Wanchu, Ajay; Singh, V. K.; Yadav, V. S.; Biswas, S.; Misra, R.; Agarwal, S. S.

In: Pathobiology, Vol. 63, No. 5, 1995, p. 288-292.

Research output: Contribution to journalArticle

Wanchu, A, Singh, VK, Yadav, VS, Biswas, S, Misra, R & Agarwal, SS 1995, 'Lack of natural killer cell augmentation in vitro by human interferon gamma in a subset of patients with systemic sclerosis', Pathobiology, vol. 63, no. 5, pp. 288-292.
Wanchu, Ajay ; Singh, V. K. ; Yadav, V. S. ; Biswas, S. ; Misra, R. ; Agarwal, S. S. / Lack of natural killer cell augmentation in vitro by human interferon gamma in a subset of patients with systemic sclerosis. In: Pathobiology. 1995 ; Vol. 63, No. 5. pp. 288-292.
@article{5171b56b6660445e863327d07ad9c763,
title = "Lack of natural killer cell augmentation in vitro by human interferon gamma in a subset of patients with systemic sclerosis",
abstract = "Systemic sclerosis (SSc) is a generalized connective tissue disorder characterized by fibrosis of skin and various viscera. Natural killer (NK) cells are a subset of lymphocytes that can lyse targets without prior sensitization. Few studies have tried to assess NK cell function in patients with SSc. To evaluate NK cell cytotoxicity in patients with SSc and to see the extent of its augmentation in vitro by human interferon (hIFN) gamma in the clinical subset of limited and diffuse cutaneous diseases, we evaluated 27 patients with SSc and 22 age- and sex-matched controls by 51Cr release assay. Fifteen patients had limited cutaneous disease (mean disease duration 6.2 ± 2.7 years) and 12 diffuse cutaneous disease (mean disease duration 5.7 ± 2.4 years). Patients with limited SSc had significantly higher baseline NK cell function than controls (p <0.05) and the augmentation following in vitro stimulation with hIFN gamma was negligible. Patients with diffuse SSc had lower baseline NK cell cytotoxicity than controls but this was not statistically significant. Augmentation with hIFN gamma in this group was comparable to controls. This study suggests that NK cells may have a role in the pathophysiology of this disease.",
keywords = "Interferon, Natural killer cells, Systemic sclerosis",
author = "Ajay Wanchu and Singh, {V. K.} and Yadav, {V. S.} and S. Biswas and R. Misra and Agarwal, {S. S.}",
year = "1995",
language = "English (US)",
volume = "63",
pages = "288--292",
journal = "Pathobiology",
issn = "1015-2008",
publisher = "S. Karger AG",
number = "5",

}

TY - JOUR

T1 - Lack of natural killer cell augmentation in vitro by human interferon gamma in a subset of patients with systemic sclerosis

AU - Wanchu, Ajay

AU - Singh, V. K.

AU - Yadav, V. S.

AU - Biswas, S.

AU - Misra, R.

AU - Agarwal, S. S.

PY - 1995

Y1 - 1995

N2 - Systemic sclerosis (SSc) is a generalized connective tissue disorder characterized by fibrosis of skin and various viscera. Natural killer (NK) cells are a subset of lymphocytes that can lyse targets without prior sensitization. Few studies have tried to assess NK cell function in patients with SSc. To evaluate NK cell cytotoxicity in patients with SSc and to see the extent of its augmentation in vitro by human interferon (hIFN) gamma in the clinical subset of limited and diffuse cutaneous diseases, we evaluated 27 patients with SSc and 22 age- and sex-matched controls by 51Cr release assay. Fifteen patients had limited cutaneous disease (mean disease duration 6.2 ± 2.7 years) and 12 diffuse cutaneous disease (mean disease duration 5.7 ± 2.4 years). Patients with limited SSc had significantly higher baseline NK cell function than controls (p <0.05) and the augmentation following in vitro stimulation with hIFN gamma was negligible. Patients with diffuse SSc had lower baseline NK cell cytotoxicity than controls but this was not statistically significant. Augmentation with hIFN gamma in this group was comparable to controls. This study suggests that NK cells may have a role in the pathophysiology of this disease.

AB - Systemic sclerosis (SSc) is a generalized connective tissue disorder characterized by fibrosis of skin and various viscera. Natural killer (NK) cells are a subset of lymphocytes that can lyse targets without prior sensitization. Few studies have tried to assess NK cell function in patients with SSc. To evaluate NK cell cytotoxicity in patients with SSc and to see the extent of its augmentation in vitro by human interferon (hIFN) gamma in the clinical subset of limited and diffuse cutaneous diseases, we evaluated 27 patients with SSc and 22 age- and sex-matched controls by 51Cr release assay. Fifteen patients had limited cutaneous disease (mean disease duration 6.2 ± 2.7 years) and 12 diffuse cutaneous disease (mean disease duration 5.7 ± 2.4 years). Patients with limited SSc had significantly higher baseline NK cell function than controls (p <0.05) and the augmentation following in vitro stimulation with hIFN gamma was negligible. Patients with diffuse SSc had lower baseline NK cell cytotoxicity than controls but this was not statistically significant. Augmentation with hIFN gamma in this group was comparable to controls. This study suggests that NK cells may have a role in the pathophysiology of this disease.

KW - Interferon

KW - Natural killer cells

KW - Systemic sclerosis

UR - http://www.scopus.com/inward/record.url?scp=0029555997&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029555997&partnerID=8YFLogxK

M3 - Article

C2 - 8724212

AN - SCOPUS:0029555997

VL - 63

SP - 288

EP - 292

JO - Pathobiology

JF - Pathobiology

SN - 1015-2008

IS - 5

ER -